Cynata Therapeutics Ltd has released a press release.
Cynata Receives Favourable Advice on Planned CLI Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- December 2018 Quarterly Report
- CYP Receives Notice of Acceptance from Aust Patent Office
- Cynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHD
- Cynata Completes Clinical Study Report in GvHD
- NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with Osteoarthritis
Later from Cynata Therapeutics
- Cynata Extends FUJIFILM Licence Option in GvHD
- March 2019 Quarterly Report
- Cynata Strengthens Board & Executive Management Team
- June 2019 Quarterly Report
- Cynata confirms receipt of indicative non-binding proposal
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics